Get the Stockscreener App
27.86
6.30%
1.65
After Hours:
27.86
Hims Hers Health Inc stock is traded at $27.86, with a volume of 10.41M.
It is up +6.30% in the last 24 hours and down -7.20% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
See More
Previous Close:
$26.21
Open:
$27.24
24h Volume:
10.41M
Relative Volume:
0.67
Market Cap:
$6.09B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
63.32
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
+8.28%
1M Performance:
-7.20%
6M Performance:
+21.98%
1Y Performance:
+225.09%
1-Day Range:
$25.94
$27.95
1-Week Range:
$24.07
$27.95
52-Week Range:
$8.14
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.86 | 6.09B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
159.65 | 375.98B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
54.72 | 135.33B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
87.86 | 71.78B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
125.56 | 41.87B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
20.85 | 39.97B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
(HIMS) Long Term Investment Analysis - Stock Traders Daily
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years - Yahoo Finance
Hims & Hers CFO sells shares worth $283,083 By Investing.com - Investing.com Nigeria
Hims & Hers health chief commercial officer sells $174,724 in stock - Investing.com Australia
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $283,039.64 in Stock - MarketBeat
Hims & Hers health chief commercial officer sells $174,724 in stock By Investing.com - Investing.com South Africa
Hims & Hers CFO sells shares worth $283,083 - Investing.com
DOCS: 3 Telemedicine Stocks Making Healthcare More Accessible - StockNews.com
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint - MSN
Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE) - Seeking Alpha
What’s Behind This Telehealth Stock’s 198% Rally? - substack.com
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - MSN
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation - MSN
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
GAMMA Investing LLC Buys 2,152 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
A 100x stock: Hims & Hers ($HIMS) - substack.com
Hims & Hers Health (NYSE:HIMS) Stock Rating Lowered by Citigroup - Defense World
Why Hims & Hers Health Stocks Are Dropping - TipRanks
Hims & Hers Stock Is Poised for a Major Surge in 2025 - MSN
Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 - GuruFocus.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownTime to Sell? - MarketBeat
Hims & Hers Stock Is Poised For A Major Surge In 2025 - Barchart
Hims & Hers Stock Is Poised for a Major Surge in 2025 - The Motley Fool
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Hims & Hers Health (NYSE:HIMS) Downgraded by Citigroup to "Sell" - MarketBeat
Hims & Hers Makes Waves: $1 Million Donation Tied to GLP-1 Support - MSN
What's Going On With Hims & Hers Health Stock? - Benzinga
Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Faces Pressure Amid FDA News - TipRanks
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - MSN
Here’s Cedar Grove Capital Management’s Investment Thesis for Hims & Hers Health (HIMS) - Insider Monkey
BTIG starts on Hims & Hers Health with ‘buy’ and $35 price target - Investing.com
BTIG Initiates Coverage of Hims & Hers Health (HIMS) with Buy Recommendation - MSN
Soleil Boughton Sells 268,932 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock - MarketBeat
Hims & Hers Health's chief legal officer sells $7.46 million in stock - Investing.com
Even Hims & Hers is giving Trump money - Yahoo! Voices
Hims & Hers donates $1 million to Trump's inauguration fund - NBC Philadelphia
BTIG Research Initiates Coverage on Hims & Hers Health (NYSE:HIMS) - MarketBeat
Hims & Hers donates $1M to Trump’s inauguration (NYSE:HIMS) - Seeking Alpha
Hims and Hers stock given Buy rating as revenue growth and GLP-1 demand remain strong - Investing.com
Hims & Hers health CFO sells shares worth $285,783 - Investing.com
Hims & Hers Health's chief commercial officer sells $50,594 in stock - Investing.com
What 12 Analyst Ratings Have To Say About Hims & Hers Health - Benzinga
Piper Sandler Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat
Hims & Hers Health (NYSE:HIMS) Given New $31.00 Price Target at Needham & Company LLC - MarketBeat
Hims and Hers stock named top pick for 2025 on growth potential—Needham - Investing.com
Top 10 executives to watch in 2025 - Modern Healthcare
JPMorgan Chase & Co. Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health Inc (HIMS) Stock Price Up 5.67% on Jan 4 - GuruFocus.com
February 14th Options Now Available For Hims & Hers Health (HIMS) - Nasdaq
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):